Cargando…
New enzyme-targeting radiosensitizer (KORTUC II) treatment for locally advanced or recurrent breast cancer
Kochi oxydol radiation therapy for unresectable carcinomas II (KORTUC II) is currently the most widely used radiosensitizer in Japan. This sensitizer is a solution consisting of 0.83% sodium hyaluronate and 0.5% hydrogen peroxide. The mixture is injected intratumorally just before radiation therapy...
Autores principales: | Shimbo, Taiju, Nakata, Mio, Yoshioka, Hiroto, Sato, Chikara, Hori, Akihiro, Kimura, Kosei, Iwamoto, Mitsuhiko, Yoshida, Ken, Uesugi, Yasuo, Akiyama, Hironori, Nihei, Keiji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8506568/ https://www.ncbi.nlm.nih.gov/pubmed/34650808 http://dx.doi.org/10.3892/mco.2021.2388 |
Ejemplares similares
-
KORTUC, a novel hydrogen peroxide‑based radiosensitizer for the enhancement of brachytherapy in patients with unresectable recurrent uterine cervical cancer
por: Shimbo, Taiju, et al.
Publicado: (2023) -
High-dose-rate interstitial brachytherapy with hypoxic radiosensitizer KORTUC II for unresectable pelvic sidewall recurrence of uterine cervical cancer: a case report
por: Nakata, Mio, et al.
Publicado: (2020) -
Non-Surgical Breast-Conserving Treatment (KORTUC-BCT) Using a New Radiosensitization Method (KORTUC II) for Patients with Stage I or II Breast Cancer
por: Ogawa, Yasuhiro, et al.
Publicado: (2015) -
A new implant device to prevent edema-associated underdosage in high-dose-rate interstitial brachytherapy of mobile tongue cancer
por: Yoshida, Ken, et al.
Publicado: (2019) -
Edema worsens target coverage in high-dose-rate interstitial brachytherapy of mobile tongue cancer: a report of two cases
por: Yoshida, Ken, et al.
Publicado: (2017)